New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses ...
Sep 23, 2025
0
0
Patient preference studies (research into what patients value in their treatment) are increasingly used to inform drug development and regulatory approval decisions. But these studies are expensive and time-consuming to conduct. ...
Sep 15, 2025
0
0
A University of Alberta-led team has identified a new way to treat post-surgical pain in animals and human cells, in a bid to find non-addictive treatments for acute and even chronic pain.
Aug 28, 2025
0
0
Nearly 80% of U.S. neurologists prescribing drugs for multiple sclerosis (MS) have received at least one pharma industry payment, with higher-volume prescribers more likely to be beneficiaries, finds a five-year analysis ...
Aug 26, 2025
0
32
A team of scientists led by the Institute for Glial Sciences (IGS) at Case Western Reserve University's School of Medicine has discovered a built-in "brake" that controls when key brain cells mature. In multiple sclerosis ...
Aug 25, 2025
0
12
By revealing the molecular mechanisms behind the peacekeeping abilities of specialized immune cells, scientists are uncovering new pathways for treating autoimmune conditions and detecting diseases like cancer.
Aug 20, 2025
0
17
Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as "relapsing" or "progressive." An international study, published on August 20, 2025, in Nature Medicine under the leadership of the ...
Aug 20, 2025
0
39
In a comprehensive study, researchers from the Department of Epidemiology at the Faculty of Medicine at the University of Augsburg have provided reliable evidence for a link between chronic inflammatory diseases and the development ...
Aug 12, 2025
0
3
The earliest warning signs of multiple sclerosis (MS) may emerge more than a decade before the first classical neurological symptoms occur, according to new research from the University of British Columbia.
Aug 1, 2025
0
56
Medicare drug plans are increasingly excluding coverage of new specialty drugs that treat complex conditions like cancers and autoimmune diseases. New research from the USC Schaeffer Center shows how these barriers may come ...
Aug 1, 2025
0
1
